Centre for Pharmacovigilance
E535461
The Centre for Pharmacovigilance is a Norwegian public health unit responsible for monitoring, assessing, and improving the safety of medicines and vaccines in Norway.
All labels observed (1)
| Label | Occurrences |
|---|---|
| Centre for Pharmacovigilance canonical | 1 |
How this entity was disambiguated
This entity first appeared as the object of triple T5651933 — resolving that mention is where its identity was fixed. The disambiguator weighed these candidate entities and picked the highlighted one (or “None”, minting a new entity). This is how homonymy is resolved: the same surface form can point to different entities.
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Centre for Pharmacovigilance Context triple: [Norwegian Institute of Public Health, hasPart, Centre for Pharmacovigilance]
-
A.
Pharmacovigilance Risk Assessment Committee
The Pharmacovigilance Risk Assessment Committee is a scientific body responsible for evaluating and monitoring the safety of human medicines and advising on risk management measures in the European Union.
-
B.
Center for Drug Evaluation and Research
The Center for Drug Evaluation and Research is the U.S. FDA division responsible for overseeing the safety, effectiveness, and quality of prescription and over-the-counter drugs.
-
C.
WHO Collaborating Centre for Drug Statistics Methodology
The WHO Collaborating Centre for Drug Statistics Methodology is a specialized World Health Organization center responsible for developing and maintaining international standards for drug classification and consumption statistics, including the ATC/DDD system.
-
D.
Pharmacovigilance Risk Assessment Committee within the European Medicines Agency
The Pharmacovigilance Risk Assessment Committee within the European Medicines Agency is an expert body responsible for evaluating and monitoring the safety of medicines across the European Union and providing recommendations on managing and communicating medicine-related risks.
-
E.
UK Medicines and Healthcare products Regulatory Agency
The UK Medicines and Healthcare products Regulatory Agency is the United Kingdom’s national authority responsible for regulating medicines, medical devices, and healthcare products to ensure their safety, quality, and effectiveness.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: Centre for Pharmacovigilance Target entity description: The Centre for Pharmacovigilance is a Norwegian public health unit responsible for monitoring, assessing, and improving the safety of medicines and vaccines in Norway.
-
A.
Pharmacovigilance Risk Assessment Committee
The Pharmacovigilance Risk Assessment Committee is a scientific body responsible for evaluating and monitoring the safety of human medicines and advising on risk management measures in the European Union.
-
B.
Center for Drug Evaluation and Research
The Center for Drug Evaluation and Research is the U.S. FDA division responsible for overseeing the safety, effectiveness, and quality of prescription and over-the-counter drugs.
-
C.
WHO Collaborating Centre for Drug Statistics Methodology
The WHO Collaborating Centre for Drug Statistics Methodology is a specialized World Health Organization center responsible for developing and maintaining international standards for drug classification and consumption statistics, including the ATC/DDD system.
-
D.
Pharmacovigilance Risk Assessment Committee within the European Medicines Agency
The Pharmacovigilance Risk Assessment Committee within the European Medicines Agency is an expert body responsible for evaluating and monitoring the safety of medicines across the European Union and providing recommendations on managing and communicating medicine-related risks.
-
E.
UK Medicines and Healthcare products Regulatory Agency
The UK Medicines and Healthcare products Regulatory Agency is the United Kingdom’s national authority responsible for regulating medicines, medical devices, and healthcare products to ensure their safety, quality, and effectiveness.
- F. None of above. chosen
Statements (25)
| Predicate | Object |
|---|---|
| instanceOf |
pharmacovigilance centre
ⓘ
public health unit ⓘ |
| aim |
protecting patients from harmful effects of medicines
ⓘ
protecting the population from harmful effects of vaccines ⓘ |
| country | Norway ⓘ |
| field |
drug safety
ⓘ
pharmacovigilance ⓘ public health ⓘ vaccine safety ⓘ |
| focus |
medicine safety surveillance
ⓘ
risk assessment of medicinal products ⓘ risk management of medicinal products ⓘ vaccine safety surveillance ⓘ |
| jurisdiction | Norway ⓘ |
| languageOfWorkOrName | Norwegian ⓘ |
| location | Norway ⓘ |
| purpose |
assessing the safety of medicines in Norway
ⓘ
assessing the safety of vaccines in Norway ⓘ improving the safety of medicines in Norway ⓘ improving the safety of vaccines in Norway ⓘ monitoring the safety of medicines in Norway ⓘ monitoring the safety of vaccines in Norway ⓘ |
| responsibility |
monitoring adverse drug reactions in Norway
ⓘ
monitoring adverse events following immunisation in Norway ⓘ |
| sector | public sector ⓘ |
How these facts were elicited
The pipeline generated the facts above by prompting gpt-5.1 with this entity's name + description and the instruction below.
Instruction
You are a knowledge base construction expert. Given a subject entity and a description of it, return factual statements that you know for the subject as a JSON list of dictionaries(triples), where keys must be "subject", "predicate" and "object". The number of facts may be very high, between 25 to 50 or more, for very popular subjects. For less popular subjects, the number of facts can be very low, like 5 or 10. # Requirements - If you don't know the subject at all, return an empty list. - If the subject is not a named entity, return an empty list. - Include at least one triple where predicate is "instanceOf". - Do not get too wordy. - Separate several objects into multiple triples with one object.
Input
Subject: Centre for Pharmacovigilance Description of subject: The Centre for Pharmacovigilance is a Norwegian public health unit responsible for monitoring, assessing, and improving the safety of medicines and vaccines in Norway.
Referenced by (1)
Full triples — surface form annotated when it differs from this entity's canonical label.